Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider Survey.
Maryia ZhdanavaH Lynn StarrPatrick LefebvreTodor I TotevAditi ShahKristy ShengDominic PilonPublished in: Neuropsychiatric disease and treatment (2022)
LAIs were commonly recommended to patients with poor adherence, and patient/caregiver involvement was an important factor affecting prescribers' treatment decisions. LAI prescribing rates remained unchanged during the COVID-19 pandemic in 2020.